ReactiWity of [Re{K3-H(µ-H)B(timMe)2}(CO)3]
of preparing pure and water stable 99mTc complexes using
very low ligand concentration. All these features highlighted
the potential relevance of model compounds 1-4 as building
blocks for the development of radiopharmaceuticals, namely
for labeling biomolecules with 99mTc or 186/188Re. On the basis
of model complexes 1-4, several approaches can be used
for the labeling of biomolecules.16,17 For complexes [M{κ3-
H(µ-H)B(timMe)2}(CO)3] (M ) Re (2a), 99/99mTc (2b)), which
present an unprecedented agostic B-H‚‚‚Tc interaction, one
of these approaches relies on the cleavage of the agostic
B-H‚‚‚M interaction by neutral substrates (L), potentially
able to be functionalized with biomolecules. An essential
prerequisite to apply this approach is to find substrates strong
enough to cleave the agostic interaction. In the search of
adequate substrates, we have decided to investigate the
possibility of adding different neutral ligands (imidazole
(imzH), 4-(dimethylamino)pyridine (4-NMe2py), tert-butyl-
isonitrile (tBuNC), triphenylphosphine (PPh3), ethylenedi-
amine (en), and 1,2-bis(diphenyl)phosphinoethane (dppe))
to complex [Re{κ3-H(µ-H)B(timMe)2}(CO)3] (2a).
microcrystalline solid was obtained by reacting 112 mg (0.22 mmol)
of 2a with excess (dimethylamino)pyridine (135 mg, 1.11 mmol).
Anal. Calcd for C18H22BN6O3ReS2: C, 34.21; H, 3.48; N, 13.30.
Found: C, 34.78; H, 2.27; N, 13.14. IR(cm-1): 1865, 1880 and
2000 (ν(CO)), 2380 and 2460 (ν(BH)). 1H NMR (300 MHz, CDCl3,
δ (ppm)): 3.02 (s, 6H, N-CH3, py*), 3.75 (s, 6H, CH3), 6.43 (d,
2H, m-py*), 6.73 (d, 2H, CH), 6.98 (d, 2H, CH), 8.52 (d, 2H,
o-py*).
Synthesis of [Re{κ3-H(µ-H)B(timMe)2}(CO)3(tBuNC)] (7). To
a suspension of [Re{κ3-H(µ-H)B(timMe)2}(CO)3] (2a) (100 mg, 0.20
t
mmol) in toluene was added excess BuNC (100 µL, 0.88 mmol),
and the reaction mixture was stirred for 24 h. Compound 7 (100
mg, 0.17 mmol, η ) 85%) was recovered as a white microcrys-
talline solid, after removal of the solvent under vacuum and washing
with n-hexane.
Anal. Calcd for C16H21BN5O3ReS2: C, 32.43; H, 3.55; N, 11.82.
Found: C, 32.58; H, 3.30; N, 11.70. IR(cm-1): 1890, 1950, and
1
2010 (ν(CO)); 2165 (ν(CN)); 2400 and 2460 (ν(BH)). H NMR
(300 MHz, CD3CN, δ (ppm)): 1.31 (s, 9H, CH3, tBu), 3.69 (s, 6H,
CH3), 6.98 (d, 2H, CH), 7.07 (d, 2H, CH).
Synthesis of [Re{κ3-H(µ-H)B(timMe)2}(CO)3(PPh3)] (8). Com-
plex 8 was prepared and recovered as described for 5 and 6. A 178
mg (0.23 mmol, η ) 58%) portion of 8 in the form of a white
microcrystalline solid was obtained by reacting 200 mg (0.40 mmol)
of 2 with excess triphenylphosphine (510 mg, 1.95 mmol).
Herein, we report on the synthesis, characterization, and
stability of the resulting mixed compounds [Re{κ2-H2B-
t
(timMe)2}(CO)3(L)] (L ) imzH (5), 4-NMe2py (6), BuNC
(7), PPh3 (8)), [Re{κ1-H2B(timMe)2}(CO)3(en)] (9), and
[Re{κ2-H2B(timMe)2}(CO)3]2(µ-dppe) (10).
Anal. Calcd for C29H27BN4O3PReS2: C, 45.10; H, 3.50; N, 7.26.
Found: C, 45.10; H, 2.92; N, 6.83. IR(cm-1): 1860, 1905 and 2000
1
(ν(CO)), 2380 and 2440 (ν(BH)). H NMR (300 MHz, CDCl3, δ
Experimental Section
(ppm)): 3.70 (s, 6H, CH3), 6.69 (d, 2H, CH), 6.98 (d, 2H, CH),
7.32-7.42 (m, 9H, CH, m+p-Ph), 7.74 (m, 6H, CH; o-Ph). 31P
NMR (121.3 MHz, CDCl3, δ (ppm)): 13.38.
General Procedures. The reactions were carried out under air,
except when indicated to the contrary. Chemicals and solvents were
of reagent grade and were used without further purification.
[Re{κ3-H(µ-H)B(timMe)2}(CO)3] (2a) was prepared as described
previously.16 1H and 31P NMR spectra were recorded on a Varian
Unity 300 MHz spectrometer; 1H chemical shifts were referenced
with the residual solvent resonances relative to tetramethylsilane,
and the 31P NMR chemical shifts with external 85% H3PO4 solution.
NMR spectra were run in CD3CN or in CDCl3. IR spectra were
recorded as KBr pellets on a Perkin-Elmer 577 spectrometer.
Carbon, hydrogen, and nitrogen analyses were performed on a
EA110 CE Instruments automatic analyzer. Although all complexes
were isolated with high chemical purity, as indicated by 1H NMR,
low values were systematically obtained for the hydrogen analysis.
Synthesis of [Re{κ3-H(µ-H)B(timMe)2}(CO)3(imzH)] (5). To
a suspension of [Re{κ3-H(µ-H)B(timMe)2}(CO)3] (2a) (200 mg, 0.40
mmol) in toluene was added imzH (130 mg, 1.9 mmol). The
reaction mixture was stirred for 24 h, and after this period of time,
the solvent was removed under vacuum. After washing the residue
with diethyl ether, to remove free imidazole, a white microcrys-
talline solid was recovered which has been formulated as 5 (140
mg, 0.24 mmol, η ) 60%).
Synthesis of [Re{κ1-H2B(timMe)2}(CO)3(en)] (9). To a solution
of compound 2a (100 mg, 0.196 mmol) in methanol was added
excess ethylenediamine (65 µL, 0.973 mmol). The resulting solution
was heated under reflux for 2 h, precipitating a white solid. After
this time, the reaction mixture was dried under vacuum, to remove
1
the solvent and excess ethylenediamine. H NMR analysis of the
crude material revealed that it contained essentially complex 9.
Further purification of 9 was achieved by recrystallization from
methanol. Yield: 70 mg (0.123 mmol, 63%).
Anal. Calcd for C16H21BN7O3ReS2: C, 27.42; H, 3.51; N, 14.76.
Found: C, 27.59; H, 2.16; N, 14.21. IR(cm-1): 1880 and 2000
(ν(CO)), 2390 and 2430 (ν(BH)), 2990-3650 ((ν(NH)). 1H NMR
(300 MHz, CD3CN, δ (ppm)): 2.72 (m, 2H, CH2, en), 3.00 (m,
2H, CH2, en), 3.43 (s, 3H, CH3), 3.72 (s, 3H, CH3), 4.10 (br, 4H,
N-H, en), 6.63 (d, 1H, CH), 6.71 (d, 1H, CH), 6.93 (d, 1H, CH),
6.96 (d, 1H, CH).
Synthesis of [Re{κ2-H2B(timMe)2}(CO)3]2(µ-dppe) (10). While
under nitrogen, dppe (20 mg, 0.05 mmol) was added to a methanolic
solution of compound 2a (50 mg, 0.098 mmol). The reaction
mixture was heated under reflux for 2 h, and while refluxing,
complex 10 began to precipitate as a white microcrystalline solid.
After cooling to room temperature, 10 was recovered by filtration,
followed by washing with methanol (2 × 5 mL) and drying under
vacuum. Yield: 46 mg (0.032 mmol, 58%).
Anal. Calcd for C14H16BN6O3ReS2: C, 29.12; H, 2.77; N, 14.67.
Found: C, 29.57; H, 2.54; N, 14.67. IR(cm-1): 1860, 1880, 1905
1
and 2000 (ν(CO)), 2400 and 2460 (ν(BH)). H NMR (300 MHz,
CD3CN, δ (ppm)): 3.65 (s, 6H, CH3), 6.92 (d, 2H, CH), 7.02 (d,
2H, CH), 7.10 (br, 1H, CH, imzH), 7.27 (br, 1H, CH, imzH), 8.09
(br, 1H, CH, imzH), 10.77 (s, 1H, NH, imzH).
Synthesis of [Re{κ3-H(µ-H)B(timMe)2}(CO)3(4-NMe2py)] (6).
Complex 6 was prepared and recovered as described for 5. A 95
mg (0.15 mmol, η ) 85%) portion of 6 in the form of a white
Anal. Calcd for C48H48B2N8O6P2Re2S4: C, 40.68; H, 3.39; N,
7.91. Found: C, 40.35; H, 2.87; N, 7.67. IR(cm-1): 1865, 1910
1
and 2000 (ν(CO)), 2400 and 2460 (ν(BH)). H NMR (300 MHz,
CDCl3, δ (ppm)): 2.70 (s, 4H, CH2, dppe), 3.66 (s, 12H, CH3),
6.67 (d, 4H, CH), 6.94 (d, 4H, CH), 7.37 (br, 12H, m+p-Ph, dppe),
7.59 (br, 8H, o-Ph, dppe). 31P NMR (121.3 MHz, CDCl3, δ
(ppm)): 7.79.
(17) Garcia, R.; Xing, Y. H.; Paulo, A.; Domingos, A.; Santos, I.
Unpublished results.
Inorganic Chemistry, Vol. 41, No. 9, 2002 2423